Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1241-1250 of 10716

Edit search filters
  1. Impact of Three vs Seven Day Stent Placement on Symptoms

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

  3. Spasticity After Spinal Cord Injury

    Rochester, MN

  4. Comparing ESG to ESG with APC

    Rochester, MN

  5. Treating Epilepsy With Transcranial Direct Current Stimulation

    Rochester, MN

  6. Autologous Induced Pluripotent Stem Cells of Cardiac Lineage Delivered Into Heart Muscle for Congenital Heart Disease

    Rochester, MN

  7. Full-Time Occlusion Therapy for Intermittent Exotropia in Children (IXT7)

    Rochester, MN

  8. Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

    Rochester, MN

  9. FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

    Scottsdale/Phoenix, AZ

  10. Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer